Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clinical Evaluation of Systemic Moxifloxacin Compared to Amoxicillin Plus Metronidazole Adjunct to Non-surgical Treatment in Generalized Aggressive Periodontitis: A Randomized Clinical Trial
Brief Summary: The objective of this randomized clinical study was to evaluate the effect of systemic administration of moxifloxacin compared to amoxicillin plus metronidazole combined with non-surgical treatment in patients with generalized aggressive periodontitis (GAgP) in 6-month follow-up.

A total of 40 systemically healthy patients with GAgP will evaluate in this randomized clinical trial. Periodontal parameters (plaque index, gingival index, probing depth, bleeding on probing, clinical attachment level) will be recorded at baseline, 1st, 3rd and 6th month. Patients will receive either 400 mg moxifloxacin per os once daily or 500 mg metronidazole and 500 mg amoxicillin per os three times daily for 7 days consecutively.


Options:
A: Arm Label: amoxicillin+metronidazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amoxicillin, Drug: Metronidazole | Arm Label: moxifloxacin; Type: EXPERIMENTAL; Interventions: Drug: Moxifloxacin | Intervention Type: DRUG; Name: Amoxicillin; Assigned to Arm(s): amoxicillin+metronidazole | Intervention Type: DRUG; Name: Metronidazole; Assigned to Arm(s): amoxicillin+metronidazole | Intervention Type: DRUG; Name: Moxifloxacin; Assigned to Arm(s): moxifloxacin
B: Arm Label: Periodontal intervention, sugar pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: Metronidazol | Intervention Type: DRUG; Name: Metronidazol; Assigned to Arm(s): Periodontal intervention, sugar pill
C: Arm Label: scaling and root planing; Type: PLACEBO_COMPARATOR; Interventions: Other: scaling and root planing | Arm Label: scaling and systemic moxifloxacin; Type: EXPERIMENTAL; Interventions: Other: scaling and systemic moxifloxacin | Intervention Type: OTHER; Name: scaling and systemic moxifloxacin; Assigned to Arm(s): scaling and systemic moxifloxacin | Intervention Type: OTHER; Name: scaling and root planing; Assigned to Arm(s): scaling and root planing
D: Arm Label: YH14642 A-I; Type: EXPERIMENTAL; Interventions: Drug: YH14642 500mg Tab | Arm Label: YH14642 A-II; Type: EXPERIMENTAL; Interventions: Drug: YH14642 500mg Tab | Arm Label: YH14642 A-III; Type: EXPERIMENTAL; Interventions: Drug: YH14642 500mg Tab | Arm Label: Active Comparator B; Type: ACTIVE_COMPARATOR; Interventions: Drug: INSADOL[Zea mays L. extract] 35mg Tab | Arm Label: Active Comparator C; Type: ACTIVE_COMPARATOR; Interventions: Drug: DENTISTA[Doxycycline hyclate] 20mg Cap | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: YH14642 500mg Tab; Assigned to Arm(s): YH14642 A-I | Intervention Type: DRUG; Name: YH14642 500mg Tab; Assigned to Arm(s): YH14642 A-II | Intervention Type: DRUG; Name: YH14642 500mg Tab; Assigned to Arm(s): YH14642 A-III | Intervention Type: DRUG; Name: INSADOL[Zea mays L. extract] 35mg Tab; Assigned to Arm(s): Active Comparator B | Intervention Type: DRUG; Name: DENTISTA[Doxycycline hyclate] 20mg Cap; Assigned to Arm(s): Active Comparator C | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A